About
Laser Particle Barcodes for Cell Analysis
Areas of Focus
Categories
Non-PharmaceuticalBoston & New England
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
232
By Phase
PHASE2: 4PHASE1: 2
By Status
COMPLETED: 7TERMINATED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT05049161Lead Sponsor
A Long-term Extension of Study GNC-401
PHASE2Terminated
33 participants
Started: Aug 27, 2021 · Completed: May 18, 2022
NCT04580537Collaborator
Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails
PHASE2Completed
11 participants
Started: Oct 2, 2020 · Completed: Jun 1, 2021
NCT04480307Lead Sponsor
Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis
PHASE2Completed
41 participants
Started: Jun 17, 2020 · Completed: Jan 24, 2022
NCT02452996Lead Sponsor
Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers
PHASE1Completed
21 participants
Started: Apr 30, 2015 · Completed: Aug 31, 2015
NCT01804647Lead Sponsor
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
N/ACompleted
58 participants
Started: Nov 30, 2012 · Completed: Feb 28, 2015
Locations (1)
Headquarters
Waltham, MA, United States
Map
Loading map...